Chow, Li Sze
Rajagopal, Heshalini
Paramesran, Raveendran
Funding for this research was provided by:
BKP (BK053-2014)
University of Malaya
Alzheimer's Disease Neuroimaging Initiative (ADNI)
National Institutes of Health (U01 AG024904)
DOD ADNI (W81XWH-12-2-0012)
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen Idec Inc.
Bristol-Myers Squibb Company
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Medpace, Inc.
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Synarc Inc.
Takeda Pharmaceutical Company
The Canadian Institutes of Rev. December 5, 2013 Health Research
This article is maintained by: Elsevier
Article Title: Correlation between subjective and objective assessment of magnetic resonance (MR) images
Journal Title: Magnetic Resonance Imaging
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.mri.2016.03.006
Content Type: article
Copyright: © 2016 Elsevier Inc. All rights reserved.